ASX Share rice
Sat 15 Aug 2020 - 06:28:pm (Sydney)

MVP Share Price

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITEDMVPPharmaceuticals, Biotechnology & Life Sciences

MVP Company Information

Name:

Medical Developments International Limited

Sector:

Healthcare

Industry:

Drug Manufacturers—Specialty & Generic

GIC Industry:

Pharmaceuticals

GIC Sub Industry:

Pharmaceuticals

Address:

4 Caribbean Drive Scoresby Australia 3179

Phone:

61 3 9547 1888

Full Time Employees:

58

CFO & Company Sec.:

Mr. Mark Edwards

Head of Sales & Marketing:

Thomas Materia

Head of HR:

Tara Collier

Chief Scientific Officer:

Dr. Scott Courtney

Head of Medical Affairs:

Michelle Bradney

Company Overview:

Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment. The company operates in three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management for use in homes, pharmacies, hospitals, medical practices, and aged care facilities; Penthrox, a prescription only medicine for pain relief; medical devices; and various veterinary anesthetic machines to veterinarians. The company operates in Australia, New Zealand, Italy, rest of Europe, the United Kingdom, Canada, the Middle East, South Africa, North America, Rest of Asia, and internationally. Medical Developments International Limited is headquartered in Scoresby, Australia.

MVP Share Price Information

Shares Issued:

65.62M

Market Capitalisation:

$414.74M

Dividend per Share:

$0.04

Ex Dividend Date:

2020-03-05

Dividend Yield:

0.63%

Revenue (TTM):

$22.25M

Revenue Per Share (TTM):

$0.34

Earnings per Share:

$0.017

Profit Margin:

0.0515

Operating Margin (TTM):

$0.16

Return On Assets (TTM):

$0.03

Return On Equity (TTM):

$0.03

Quarterly Revenue Growth (YOY):

0.144

Gross Profit(TTM):

$14.18M

Diluted Earnings Per Share (TTM):

$0.017

QuarterlyEarnings Growth(YOY):

0.714

MVP CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-9,535,000

Change To Liabilities:

$202K

Total Cashflow From Investing Activities:

$-9,535,000

Net Borrowings:

$-9,070,000

Net Income:

$1.04M

Total Cash From Operating Activities:

$21.27M

Depreciation:

$1.19M

Other Cashflow From Investing Activities:

$330K

Dividends Paid:

$-1,717,000

Change To Inventory:

$148K

Change To Account Receivables:

$-2,097,000

Sale Purchase Of Stock:

$-1,045,000

Capital Expenditures:

$9.87M

MVP Income Statement

Income Date:

2019-06-30

Income Before Tax:

$1.55M

Net Income:

$1.04M

Gross Profit:

$14.18M

Operating Income:

$1.17M

Other Operating Expenses:

$1.34M

Interest Expense:

$71K

Income Tax Expense:

$513K

Total Revenue:

$20.88M

Total Operating Expenses:

$13.01M

Cost Of Revenue:

$6.69M

MVP Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$29.67M

Total Liabilities:

$40.21M

Total Stockholder Equity:

$44.59M

Other Current Liabilities:

$2.52M

Total Assets:

$84.80M

Common Stock:

$40.41M

Retained Earnings:

$2.67M

Other Liabilities:

$31.73M

Good Will:

$9.10M

Other Assets:

$29.85M

Cash:

$25.62M

Total Current Liabilities:

$8.40M

Short-Term Debt:

$91K

Property - Plant & Equipment:

$8.56M

Net Tangible Assets:

$33.55M

Total Current Assets:

$35.35M

Long-Term Debt:

$91K

Net Receivables:

$6.27M

Short-Term Investments:

$49.45M

Inventory:

$3.05M

Accounts Payable:

$2.03M

Non Currrent Assets (Other):

$-1,000

Short-Term Investments:

$49.45

Non Current Liabilities (Other):

$31.43M

Non Current Liabilities Total:

$31.82M

MVP Share Price History

MVP News

10 Jul, 2020
The big shareholder groups in Medical Developments International Limited (ASX:MVP) have power over the company...
22 Apr, 2020
Most readers would already be aware that Medical Developments International's (ASX:MVP) stock increased significantly...
21 Feb, 2020
Last week, you might have seen that Medical Developments International Limited (ASX:MVP) released its half-year result...
14 Jan, 2020
John Sharman has been the CEO of Medical Developments International Limited (ASX:MVP) since 2010. This report will...
15 Nov, 2019
We think all investors should try to buy and hold high quality multi-year winners. And highest quality companies can...

MVP Dividend Payments

EX-Date Dividend Amount
2011-08-31$0.0300
2012-02-27$0.0300
2012-08-30$0.0300
2013-02-26$0.0300
2013-09-02$0.0200
2016-03-01$0.0200
2016-09-01$0.0200
2017-03-02$0.0200
2017-08-31$0.0200
2018-03-01$0.0200
2018-08-30$0.0200
2019-03-06$0.0200
2019-09-03$0.0200
2020-03-04$0.0200

MVP Dividends (last 8 Years)